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Introduction
Meconium peritonitis is defined as a sterile reaction in
the fetal abdomen resulting from intrauterine bowel
perforation. It occurs in one in every 35,000 live births
[1]. The intense inflammatory reaction forms a dense,
adherent membrane that effectively seals off the intestine
at the site of perforation. If, however, the perforation is
not totally sealed, a thick-walled cystic cavity forms, and
meconium will continue to enter this cystic space. The
meconium cyst may entrap or compress the surrounding
intestines [2,3]. The association of meconium peritonitis
with maternal prenatal cocaine abuse has been reported
in the literature, with the authors attributing it to the
vascular effects of cocaine [4]. Amphetamines, a group
of sympathomimetic drugs, have pharmacologic ef-
fects similar to cocaine. Members of this group include
amphetamine, dextroamphetamine and methamphet-
amine. They are powerful _-adrenergic stimulants and
induce the release of catecholamines from adrenergic
synapses [5].
Here, we report a case of meconium pseudocyst in a
baby whose mother abused methamphetamine and
heroin during pregnancy. The possible relationship
between drug effects and meconium peritonitis is
discussed.
SUMMARY
Objective: In roughly 50% of all patients with meconium peritonitis, there is no evidence of primary obstruction
of the bowel. We report a case of maternal methamphetamine and heroin abuse complicated by fetal meconium
pseudocyst without a definite intestinal obstructive lesion. We discuss the correlation between the presence
of meconium peritonitis and prenatal exposure to methamphetamine.
Case Report: A 19-year-old, gravida 2, para 0, abortus 1, woman had abused illegal drugs, including
methamphetamine and intravenous heroin. Suffering from withdrawal symptoms, she was taken to a shelter
where she was diagnosed with a pregnancy of 26 weeks’ gestation. The patient underwent cesarean section
at 34 weeks due to preterm labor and fetal malpresentation. A boy weighing 2,474 g was born, but had to
be intubated and admitted to the intensive care unit because of a distended abdomen and respiratory distress.
A laparotomy performed on the second day of life revealed a large calcified pseudocyst associated with two
perforations of the distal jejunum. A segmental resection of the jejunum with primary anastomosis was
performed. The infant recovered well after the operation and was discharged 65 days after birth.
Conclusion: Since methamphetamine is a powerful _-adrenergic stimulant and induces the release of
catecholamines from adrenergic synapses, it can cause powerful vessel constriction. Prenatal exposure to
methamphetamine can cause disruption of mesenteric blood flow with transmural necrosis of the bowel, resulting
in bowel perforation and meconium peritonitis. [Taiwanese J Obstet Gynecol 2005;44(2):180–182]
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Case Report
A 19-year-old, gravida 2, para 0, abortus 1, woman had
abused illegal drugs, including methamphetamine (by
inhalation for 6–7 years) and heroin (injected intra-
venously in the previous 6 months). Suffering from
withdrawal symptoms, she was taken to a shelter where
she was diagnosed with a pregnancy of 26 weeks’
gestation. She presented for prenatal care at 28 weeks;
ultrasound showed a fetus with biometric data appro-
priate for gestational age. However, polyhydramnios
and fetal ascites with a large echogenic cyst (7.23 =
3.26 cm) in the left upper abdominal cavity were present
(Figure). Amniocentesis revealed a 46XY karyotype. The
mother’s urinary methamphetamine concentration was
788 ng/mL, with opiate metabolites of 448 ng/mL.
The patient underwent cesarean section at 34 weeks
due to preterm labor and fetal malpresentation. A boy
weighing 2,474 g was born, with Apgar scores of 5 and
9 at 1 and 5 minutes, respectively. The baby was intu-
bated and admitted to the intensive care unit because
of a distended abdomen and respiratory distress. A
laparotomy performed on the second day of life revealed
a large calcified pseudocyst associated with two per-
forations of the distal jejunum. A segmental resection of
the jejunum with primary anastomosis was performed.
The infant recovered well after the operation and was
discharged 65 days after birth.
Discussion
Meconium peritonitis is the result of an intrauterine
perforation of the small bowel or, rarely, other sites of
the gastrointestinal tract [2,3]. It may occur as early as
24 weeks of gestation [6]. In 50% of cases, a definite
obstructive lesion can be demonstrated, the most
common being volvulus, atresia, intussusception,
vascular insufficiency, duplication, stenosis, congenital
bands, cystic fibrosis, meconium plugs, imperforate
anus, Meckel’s diverticulum, hyperplastic lymphoid
tissue and colonic aganglionosis [2,7]. In addition,
bowel ischemia secondary to prenatal anoxic events
may cause perforation with subsequent meconium
peritonitis [8,9].
Lloyd suggested that intestinal perforation is
associated with diminished mesenteric blood flow due
to perinatal asphyxia [10]. Tibboel et al hypothesized
that a temporary reduction in mesenteric blood flow
may lead to necrosis of the mucosa, which may in turn
cause complete obstruction of the intestinal lumen,
resulting in atresia of the small bowel [11]. Persistent
reduction of mesenteric blood flow can lead to
transmural bowel necrosis. Depending on the rate of
this process, perforation may occur, resulting in
meconium peritonitis without intestinal atresia [11].
Amphetamine is a phenylisopropylamine and is
structurally similar to endogenous catecholamines
and neurotransmitters. It is a powerful _-adrenergic
stimulant that induces the release of catecholamines
from adrenergic synapses, which are then primarily
responsible for the peripheral actions of the drug. Ma-
ternal use of amphetamines during pregnancy carries a
significant risk of intrauterine growth retardation and
premature delivery [12]. Methamphetamine is very
similar to amphetamine, but has a higher ratio of
central to peripheral effects [5]. In near-term pregnant
sheep given intravenous amphetamine at or below
commonly used recreational doses, methamphetamine
rapidly crossed the placenta and accumulated in the
fetus [13,14]. Fetal ovine blood pressure increased 20–
37% with a decrease in fetal oxyhemoglobin saturation
and arterial pH. Methamphetamine has pharmacologic
effects similar to cocaine, including vasoconstriction
and infarction [15]. Cocaine, a potent vasoconstrictor,
is strongly suspected to be a teratogen. Maternal cocaine
administration may impose notorious effects on the
developing fetus via cocaine-induced maternal uterine
hypoperfusion and hypoxemia [16], and direct cocaine-
mediated vasospasm, hypertension, and tachycardia
with subsequent microregional infarction [17]. This
could lead to loss of an existing structure, or stricture of
that structure; utero-intracranial vascular accidents,
transverse limb defects, and necrotizing enterocolitis
following cocaine exposure support such a mechanism
[4,18,19].
Fetuses exposed to cocaine have exhibited various
disruptive pathogenic vascular anomalies, including
complex choroid cysts, gastroschisis, meconium peri-
Figure. Ultrasound of the fetus (transverse abdomen) at 28
weeks of gestation shows the presence of fetal ascites (thin
arrow) and a large echogenic cyst (thick arrow).
W.J. Yang, et al
Taiwanese J Obstet Gynecol • June 2005 • Vol 44 • No 2182
tonitis, urethral stenosis, and radial hypoplasia [4,
20]. Similarly, cerebral injuries occurring in newborns
exposed to methamphetamine or cocaine in utero appear
to be directly related to the vasoconstrictive properties
of those drugs [21]. Retrospective human studies and
case reports have linked amphetamines to congenital
heart disease, biliary atresia, and limb reduction [22,
23]. All of these manifestations are related to disrup-
tion of the circulation and vasculogenesis during
embryogenesis [22].
In general, the frequency of congenital anomalies is
not higher among infants born to mothers addicted to
heroin, but there is a significantly higher rate of morbidity,
including preterm labor, fetal growth restriction, and
prenatal death [24]. Women who used heroin during
pregnancy tended also to use other substances (tobacco,
cocaine, etc.) more often than did controls [24]. In our
case, we believe that meconium peritonitis most likely
occurred because of methamphetamine-induced
mesenteric vasoconstriction leading to bowel ischemia
and perforation. However, the exact risk of it occurring
in an individual methamphetamine-exposed pregnancy
remains unknown. Large cohort studies may be necessary
to define this risk further.
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